Lv7
5000 积分 2024-04-01 加入
Cancer burden and control in China: landscape, trends and challenges
26天前
已完结
Structural insights into IL-31 signaling inhibition by a neutralizing antibody
1个月前
已完结
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
1个月前
已完结
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
1个月前
已完结
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
1个月前
已完结
Advances in targeting IL-1 family cytokines for the treatment of inflammatory diseases
1个月前
已完结
Structural and Functional Insights Into IgE Receptor Interactions and Disruptive Inhibition
1个月前
已完结
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
2个月前
已完结
Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131)
2个月前
已完结
Prostatic acid phosphatase: a rediscovered target in prostate cancer
2个月前
已完结
皖公网安备34019202002308
